Menu
Recruiting NCT06751797

Balance Confidence and Kinesiophobia in Parkinson's Disease

— Observational Parkinson Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Parkinson Disease. Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Balance Confidence, Kinesiophobia, and Associated Factors in Parkinson's Disease: A Controlled Study

Overview

31 patients aged 50-80 years diagnosed with idiopathic Parkinson's disease (Modified Hoehn-Yahr stages 1-3) and 31 healthy volunteers. At the start of the study, sociodemographic data for all participants will be recorded. To assess the mental and functional status of Parkinson's disease patients, the Mini-Mental State Examination (MMSE) and the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) will be used. Balance confidence levels will be assessed using the Activities-specific Balance Confidence Scale-6 (ABC-6), overall balance using the Berg Balance Scale (BBS), fear of falling using the Falls Efficacy Scale (FES), and kinesiophobia levels using the Tampa Scale of Kinesiophobia (TSK).

Interventions

  • Other No intervention
    No intervention

Primary outcome measures

  • Balance Confidence (ABC-6 Scale) [Time frame: Baseline]
Secondary outcome measures (5)
  • Balance Level (Berg Balance Scale) [Time frame: Baseline]
  • Fear of Falling (Falls Efficacy Scale) [Time frame: Baseline]
  • Kinesiophobia (Tampa Scale of Kinesiophobia) [Time frame: Baseline]
  • Mental Status (MMSE) [Time frame: Baseline]
  • Functional status (MDS-UPDRS) [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Diagnosis of Idiopathic Parkinson's Disease by a neurology specialist.
  • Modified Hoehn-Yahr Staging Scale classification between stages 1-3.
  • Mini-Mental State Examination (MMSE) score of 24 or higher.
  • Age between 50-80 years.
  • Volunteered to participate in the study.

Exclusion criteria

  • Use of medications, apart from routine Parkinson's disease treatments, that could affect balance or muscle strength.
  • Presence of neurological or musculoskeletal conditions other than Parkinson's disease.
  • Refusal to participate in the study.
  • Presence of psychiatric disorders.
  • Presence of cognitive impairments.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Beylikdüzü State Hospital — Istanbul

Identifiers

NCT: NCT06751797 · BeylikduzuStateH13

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗